Gold Fields Limited (ADR) (GFI) Reaches $3.91 After 3.00% Up Move; Genesis Healthcare (GEN) SI Decreased By 9.07%

November 14, 2017 - By Marie Mckinney

The stock of Gold Fields Limited (ADR) (NYSE:GFI) is a huge mover today! About 3.25M shares traded. Gold Fields Limited (ADR) (NYSE:GFI) has declined 7.35% since November 14, 2016 and is downtrending. It has underperformed by 24.05% the S&P500.The move comes after 7 months positive chart setup for the $3.32B company. It was reported on Nov, 14 by Barchart.com. We have $4.03 PT which if reached, will make NYSE:GFI worth $99.60M more.

Genesis Healthcare Incorporated (NYSE:GEN) had a decrease of 9.07% in short interest. GEN’s SI was 2.92 million shares in November as released by FINRA. Its down 9.07% from 3.21M shares previously. With 304,300 avg volume, 10 days are for Genesis Healthcare Incorporated (NYSE:GEN)’s short sellers to cover GEN’s short positions. About 60,220 shares traded. Genesis Healthcare Inc (NYSE:GEN) has risen 29.94% since November 14, 2016 and is uptrending. It has outperformed by 13.24% the S&P500.

Genesis Healthcare, Inc. is a holding firm that provides post-acute care. The company has market cap of $140.77 million. The Firm operates through three divisions: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services. It currently has negative earnings. As of December 31, 2016, the Company offered inpatient services through its network of 499 skilled nursing and assisted/senior living facilities across 34 states, consisting of 473 skilled nursing facilities and 26 stand-alone assisted/senior living facilities.

Among 5 analysts covering Genesis Healthcare (NYSE:GEN), 1 have Buy rating, 2 Sell and 2 Hold. Therefore 20% are positive. Genesis Healthcare had 16 analyst reports since August 10, 2015 according to SRatingsIntel. The firm has “Hold” rating by RBC Capital Markets given on Thursday, August 10. UBS maintained Genesis Healthcare Inc (NYSE:GEN) on Monday, November 9 with “Neutral” rating. The firm has “Hold” rating given on Monday, July 17 by RBC Capital Markets. The stock of Genesis Healthcare Inc (NYSE:GEN) earned “Neutral” rating by Susquehanna on Tuesday, January 26. RBC Capital Markets maintained the stock with “Outperform” rating in Tuesday, January 26 report. Bank of America downgraded Genesis Healthcare Inc (NYSE:GEN) on Monday, May 16 to “Underperform” rating. The rating was maintained by RBC Capital Markets on Monday, September 11 with “Hold”. RBC Capital Markets maintained the stock with “Outperform” rating in Monday, May 16 report. The rating was downgraded by UBS on Monday, February 8 to “Sell”. The firm earned “Sector Perform” rating on Monday, November 21 by RBC Capital Markets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com